Supplement fisetin tested for rare immune lung condition
Disease control
ENROLLING_BY_INVITATION
This study tests whether the supplement fisetin can help control interstitial lung disease in people with common variable immunodeficiency (CVID). About 20 adults with CVID and related lung problems will receive either fisetin or a placebo. The goal is to see if fisetin improves …
Phase: PHASE2 • Sponsor: Avni Joshi • Aim: Disease control
Last updated May 17, 2026 05:06 UTC